Literature DB >> 34320406

Nascent RNA scaffolds contribute to chromosome territory architecture and counter chromatin compaction.

Kevin Michael Creamer1, Heather Jill Kolpa1, Jeanne Bentley Lawrence2.   

Abstract

Nuclear chromosomes transcribe far more RNA than required to encode protein. Here we investigate whether non-coding RNA broadly contributes to cytological-scale chromosome territory architecture. We develop a procedure that depletes soluble proteins, chromatin, and most nuclear RNA from the nucleus but does not delocalize XIST, a known architectural RNA, from an insoluble chromosome "scaffold." RNA-seq analysis reveals that most RNA in the nuclear scaffold is repeat-rich, non-coding, and derived predominantly from introns of nascent transcripts. Insoluble, repeat-rich (C0T-1) RNA co-distributes with known scaffold proteins including scaffold attachment factor A (SAF-A), and distribution of these components inversely correlates with chromatin compaction in normal and experimentally manipulated nuclei. We further show that RNA is required for SAF-A to interact with chromatin and for enrichment of structurally embedded "scaffold attachment regions" prevalent in euchromatin. Collectively, the results indicate that long nascent transcripts contribute a dynamic structural role that promotes the open architecture of active chromosome territories. Published by Elsevier Inc.

Entities:  

Keywords:  HNRNPU; NUMA; SAF-A; XIST; chromatin-associated RNA; nascent RNA; nuclear matrix; nuclear scaffold; nucleus; scaffold-attachment regions

Mesh:

Substances:

Year:  2021        PMID: 34320406      PMCID: PMC8419111          DOI: 10.1016/j.molcel.2021.07.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  86 in total

1.  Stable C0T-1 repeat RNA is abundant and is associated with euchromatic interphase chromosomes.

Authors:  Lisa L Hall; Dawn M Carone; Alvin V Gomez; Heather J Kolpa; Meg Byron; Nitish Mehta; Frank O Fackelmayer; Jeanne B Lawrence
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

2.  An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles.

Authors:  Christine M Clemson; John N Hutchinson; Sergio A Sara; Alexander W Ensminger; Archa H Fox; Andrew Chess; Jeanne B Lawrence
Journal:  Mol Cell       Date:  2009-02-12       Impact factor: 17.970

3.  Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain.

Authors:  Roger Helbig; Frank O Fackelmayer
Journal:  Chromosoma       Date:  2003-11-08       Impact factor: 4.316

4.  A Detailed Protocol for Subcellular RNA Sequencing (subRNA-seq).

Authors:  Andreas Mayer; L Stirling Churchman
Journal:  Curr Protoc Mol Biol       Date:  2017-10-02

Review 5.  Experimental observations of a nuclear matrix.

Authors:  J Nickerson
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

6.  Cyclin E is recruited to the nuclear matrix during differentiation, but is not recruited in cancer cells.

Authors:  Jennifer Munkley; Nikki A Copeland; Victoria Moignard; John R P Knight; Erin Greaves; Simon A Ramsbottom; Mary E Pownall; Jennifer Southgate; Justin F-X Ainscough; Dawn Coverley
Journal:  Nucleic Acids Res       Date:  2010-11-24       Impact factor: 16.971

7.  Association of chromosome territories with the nuclear matrix. Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins.

Authors:  H Ma; A J Siegel; R Berezney
Journal:  J Cell Biol       Date:  1999-08-09       Impact factor: 10.539

8.  Transformation-induced changes in the DNA-nuclear matrix interface, revealed by high-throughput analysis of DNA halos.

Authors:  Rosemary H C Wilson; Dawn Coverley
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 9.  XIST RNA: a window into the broader role of RNA in nuclear chromosome architecture.

Authors:  K M Creamer; J B Lawrence
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

Review 10.  The senescent cell epigenome.

Authors:  Na Yang; Payel Sen
Journal:  Aging (Albany NY)       Date:  2018-11-03       Impact factor: 5.682

View more
  8 in total

Review 1.  A lifelong duty: how Xist maintains the inactive X chromosome.

Authors:  Elsie C Jacobson; Amy Pandya-Jones; Kathrin Plath
Journal:  Curr Opin Genet Dev       Date:  2022-06-16       Impact factor: 4.665

2.  An added layer of repression for human genes.

Authors:  Michael Uckelmann; Chen Davidovich
Journal:  Nature       Date:  2022-04       Impact factor: 69.504

Review 3.  Phase Separation in the Nucleus and at the Nuclear Periphery during Post-Mitotic Nuclear Envelope Reformation.

Authors:  Klizia Maccaroni; Mattia La Torre; Romina Burla; Isabella Saggio
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

4.  Genome-Directed Cell Nucleus Assembly.

Authors:  Sergey V Razin; Sergey V Ulianov
Journal:  Biology (Basel)       Date:  2022-05-05

Review 5.  Merging Established Mechanisms with New Insights: Condensates, Hubs, and the Regulation of RNA Polymerase II Transcription.

Authors:  Megan Palacio; Dylan J Taatjes
Journal:  J Mol Biol       Date:  2021-08-30       Impact factor: 5.469

6.  SAF-A mutants disrupt chromatin structure through dominant negative effects on RNAs associated with chromatin.

Authors:  Heather J Kolpa; Kevin M Creamer; Lisa L Hall; Jeanne B Lawrence
Journal:  Mamm Genome       Date:  2021-12-02       Impact factor: 3.224

7.  A TET1-PSPC1-Neat1 molecular axis modulates PRC2 functions in controlling stem cell bivalency.

Authors:  Xin Huang; Nazym Bashkenova; Yantao Hong; Cong Lyu; Diana Guallar; Zhe Hu; Vikas Malik; Dan Li; Hailin Wang; Xiaohua Shen; Hongwei Zhou; Jianlong Wang
Journal:  Cell Rep       Date:  2022-06-07       Impact factor: 9.995

Review 8.  Long RNA-Mediated Chromatin Regulation in Fission Yeast and Mammals.

Authors:  Matthew W Faber; Tommy V Vo
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.